Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
2.11 USD
-2.31%
Market Closed
Updated:
May 4, 2024
Compugen Ltd
Operating Expenses
|
Compugen Ltd
Operating Expenses Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Operating Expenses
-$44.4m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-12%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Operating Expenses
-$9.4m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Operating Expenses
-₪10.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
9%
|
See Also
What is Compugen Ltd's Operating Expenses?
Operating Expenses
-44.4m
USD
-44.4m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Operating Expenses amounts to -44.4m USD.
What is Compugen Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-12%
-12%
Over the last year, the Operating Expenses growth was -6%. The average annual Operating Expenses growth rates for Compugen Ltd have been -10% over the past three years , -2% over the past five years , and -12% over the past ten years .
You don't have any saved screeners yet
